{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:45:25Z","timestamp":1794620725307,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","award":["UC Davis-Taiwan Collaborative Research Fund in memory of Larry Vanderhoef"],"award-info":[{"award-number":["UC Davis-Taiwan Collaborative Research Fund in memory of Larry Vanderhoef"]}],"id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","award":["2025"],"award-info":[{"award-number":["2025"]}],"id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"DOI":"10.1186\/s13578-025-01469-9","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:21:39Z","timestamp":1759407699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cross-ancestry discovery of genetic risk variants for lean metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Shan-Wei","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Rou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Hsuan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jui Yvonne","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"1469_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29:S32-s42.","journal-title":"Clin Mol Hepatol"},{"key":"1469_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/apt.15673","volume":"51","author":"C Estes","year":"2020","unstructured":"Estes C, Chan HLY, Chien RN, Chuang WL, Fung J, Goh GB, et al. Modelling NAFLD disease burden in four Asian regions-2019-2030. Aliment Pharmacol Ther. 2020;51:801\u201311.","journal-title":"Aliment Pharmacol Ther"},{"key":"1469_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010278","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul P, Suparan K, Kim D, Wijarnpreecha K. What is new in metabolic dysfunction-associated steatotic liver disease in lean individuals: from bench to bedside. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13010278.","journal-title":"J Clin Med"},{"key":"1469_CR4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.jhep.2019.12.013","volume":"72","author":"I Adant","year":"2020","unstructured":"Adant I, Declercq M, Bird M, Bauters M, Boeckx N, Devriendt K, et al. Two cases of non-alcoholic fatty liver disease caused by biallelic ABHD5 mutations. J Hepatol. 2020;72:1030\u20132.","journal-title":"J Hepatol"},{"key":"1469_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100692","volume":"5","author":"M Zheng","year":"2023","unstructured":"Zheng M, Huang DQ, Konkwo C, Agrawal S, Khera AV, Loomba R, et al. Genomic analysis of lean individuals with NAFLD identifies monogenic disorders in a prospective cohort study. JHEP Rep. 2023;5:100692.","journal-title":"JHEP Rep"},{"key":"1469_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/tgh-23-31","volume":"9","author":"B Njei","year":"2024","unstructured":"Njei B, Al-Ajlouni YA, Ugwendum D, Abdu M, Forjindam A, Mohamed MF. Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review. Transl Gastroenterol Hepatol. 2024;9:11.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"1469_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","volume":"73","author":"QM Anstee","year":"2020","unstructured":"Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, et al. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606). J Hepatol. 2020;73:505\u201315.","journal-title":"J Hepatol"},{"key":"1469_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100437","volume":"2","author":"N Ghodsian","year":"2021","unstructured":"Ghodsian N, Abner E, Emdin CA, Gobeil \u00c9, Taba N, Haas ME, et al. Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell Rep Med. 2021;2:100437.","journal-title":"Cell Rep Med"},{"key":"1469_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010106","author":"SA Sulaiman","year":"2022","unstructured":"Sulaiman SA, Dorairaj V, Adrus MNH. Genetic polymorphisms and diversity in nonalcoholic fatty liver disease (NAFLD): a mini review. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines11010106.","journal-title":"Biomedicines"},{"key":"1469_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/gutjnl-2020-322564","volume":"71","author":"R Younes","year":"2022","unstructured":"Younes R, Govaere O, Petta S, Miele L, Tiniakos D, Burt A, et al. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? Gut. 2022;71:382\u201390.","journal-title":"Gut"},{"key":"1469_CR11","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386.","journal-title":"Hepatology"},{"key":"1469_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11192696","author":"A Solomon","year":"2023","unstructured":"Solomon A, Negrea MO, Cip\u0103ian CR, Boicean A, Mihaila R, Rezi C, et al. Interactions between metabolic syndrome, MASLD, and arterial stiffening: a single-center cross-sectional study. Healthcare. 2023. https:\/\/doi.org\/10.3390\/healthcare11192696.","journal-title":"Healthcare"},{"key":"1469_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.clnu.2018.08.008","volume":"38","author":"AY Wang","year":"2019","unstructured":"Wang AY, Dhaliwal J, Mouzaki M. Lean non-alcoholic fatty liver disease. Clin Nutr. 2019;38:975\u201381.","journal-title":"Clin Nutr"},{"key":"1469_CR14","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/hep4.1519","volume":"4","author":"S Young","year":"2020","unstructured":"Young S, Tariq R, Provenza J, Satapathy SK, Faisal K, Choudhry A, et al. Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis. Hepatol Commun. 2020;4:953\u201372.","journal-title":"Hepatol Commun"},{"key":"1469_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739\u201352.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1469_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3350\/cmh.2023.0061","volume":"29","author":"HS Chun","year":"2023","unstructured":"Chun HS, Lee M. Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different? Clin Mol Hepatol. 2023;29:377\u201380.","journal-title":"Clin Mol Hepatol"},{"key":"1469_CR17","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.cgh.2022.06.029","volume":"21","author":"A Tang","year":"2023","unstructured":"Tang A, Ng CH, Phang PH, Chan KE, Chin YH, Fu CE, et al. Comparative burden of metabolic dysfunction in lean NAFLD vs Non-lean NAFLD\u2014a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:1750-1760.e1712.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1469_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cld.2023.01.011","volume":"27","author":"A Duseja","year":"2023","unstructured":"Duseja A, De A, Wong V. Special population: lean nonalcoholic fatty liver disease. Clin Liver Dis. 2023;27:451\u201369.","journal-title":"Clin Liver Dis"},{"key":"1469_CR19","unstructured":"[https:\/\/www.twbiobank.org.tw]"},{"key":"1469_CR20","unstructured":"Organization WH: The Asia-Pacific perspective: redefining obesity and its treatment. 2000."},{"key":"1469_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7570\/jomes23031","volume":"32","author":"JH Haam","year":"2023","unstructured":"Haam JH, Kim BT, Kim EM, Kwon H, Kang JH, Park JH, et al. Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr. 2023;32:121\u20139.","journal-title":"J Obes Metab Syndr"},{"key":"1469_CR22","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1038\/s41467-024-49224-x","volume":"15","author":"SM Johnson","year":"2024","unstructured":"Johnson SM, Bao H, McMahon CE, Chen Y, Burr SD, Anderson AM, et al. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein. Nat Commun. 2024;15:4847.","journal-title":"Nat Commun"},{"key":"1469_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2024.101761","author":"CW Lu","year":"2024","unstructured":"Lu CW, Chou TJ, Wu TY, Lee YH, Yang HJ, Huang KC. PNPLA3 and SAMM50 variants are associated with lean nonalcoholic fatty liver disease in Asian population. Ann Hepatol. 2024. https:\/\/doi.org\/10.1016\/j.aohep.2024.101761.","journal-title":"Ann Hepatol"},{"key":"1469_CR24","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/2211-5463.13146","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Shen W, Wu G, Qin C, Zhang Y, Wang Y, et al. The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms. FEBS Open Bio. 2021;11:1893\u2013906.","journal-title":"FEBS Open Bio"},{"key":"1469_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10769-0","author":"SW Wang","year":"2025","unstructured":"Wang SW, Wang C, Cheng YM, Chen CY, Hsieh TH, Wang CC, et al. Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study. Hepatol Int. 2025. https:\/\/doi.org\/10.1007\/s12072-024-10769-0.","journal-title":"Hepatol Int"},{"key":"1469_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5009\/gnl17306","volume":"12","author":"GE Chung","year":"2018","unstructured":"Chung GE, Lee Y, Yim JY, Choe EK, Kwak MS, Yang JI, et al. Genetic polymorphisms of PNPLA3 and SAMM50 are associated with nonalcoholic fatty liver disease in a Korean population. Gut Liver. 2018;12:316\u201323.","journal-title":"Gut Liver"},{"key":"1469_CR27","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1016\/j.cgh.2023.04.024","volume":"21","author":"C Rosso","year":"2023","unstructured":"Rosso C, Caviglia GP, Birolo G, Armandi A, Pennisi G, Pelusi S, et al. Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2023;21:3314-3321.e3313.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1469_CR28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cgh.2019.08.011","volume":"18","author":"S Grimaudo","year":"2020","unstructured":"Grimaudo S, Pipitone RM, Pennisi G, Celsa C, Camm\u00e0 C, Di Marco V, et al. Association between PNPLA3 rs738409 C>G variant and liver-related outcomes in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2020;18:935-944.e933.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1469_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014324","volume":"98","author":"G Dai","year":"2019","unstructured":"Dai G, Liu P, Li X, Zhou X, He S. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: a meta-analysis. Medicine. 2019;98:e14324.","journal-title":"Medicine"},{"key":"1469_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12902-021-00789-4","volume":"21","author":"N Salari","year":"2021","unstructured":"Salari N, Darvishi N, Mansouri K, Ghasemi H, Hosseinian-Far M, Darvishi F, et al. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. BMC Endocr Disord. 2021;21:125.","journal-title":"BMC Endocr Disord"},{"key":"1469_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.27242","volume":"61","author":"E Smagris","year":"2015","unstructured":"Smagris E, BasuRay S, Li J, Huang Y, Lai KM, Gromada J, et al. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology. 2015;61:108\u201318.","journal-title":"Hepatology"},{"key":"1469_CR32","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1172\/JCI65179","volume":"122","author":"JZ Li","year":"2012","unstructured":"Li JZ, Huang Y, Karaman R, Ivanova PT, Brown HA, Roddy T, et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J Clin Invest. 2012;122:4130\u201344.","journal-title":"J Clin Invest"},{"key":"1469_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12916-021-02087-1","volume":"19","author":"EL Harshfield","year":"2021","unstructured":"Harshfield EL, Fauman EB, Stacey D, Paul DS, Ziemek D, Ong RMY, et al. Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci. BMC Med. 2021;19:232.","journal-title":"BMC Med"},{"key":"1469_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100436","volume":"3","author":"CY Chen","year":"2023","unstructured":"Chen CY, Chen TT, Feng YA, Yu M, Lin SC, Longchamps RJ, et al. Analysis across Taiwan Biobank, Biobank Japan, and UK Biobank identifies hundreds of novel loci for 36 quantitative traits. Cell Genom. 2023;3:100436.","journal-title":"Cell Genom"},{"key":"1469_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","volume":"91","author":"ZM Younossi","year":"2012","unstructured":"Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine. 2012;91:319\u201327.","journal-title":"Medicine"},{"key":"1469_CR36","doi-asserted-by":"publisher","first-page":"G84","DOI":"10.1152\/ajpgi.00118.2019","volume":"318","author":"SAM Albhaisi","year":"2020","unstructured":"Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. Am J Physiol Gastrointest Liver Physiol. 2020;318:G84-g98.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1469_CR37","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836\u201346.","journal-title":"Hepatology"},{"key":"1469_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-0038-1677517","volume":"39","author":"R Younes","year":"2019","unstructured":"Younes R, Bugianesi E. NASH in lean individuals. Semin Liver Dis. 2019;39:86\u201395.","journal-title":"Semin Liver Dis"},{"key":"1469_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11154-020-09621-1","volume":"22","author":"S Maier","year":"2021","unstructured":"Maier S, Wieland A, Cree-Green M, Nadeau K, Sullivan S, Lanaspa MA, et al. Lean NAFLD: an underrecognized and challenging disorder in medicine. Rev Endocr Metab Disord. 2021;22:351\u201366.","journal-title":"Rev Endocr Metab Disord"},{"key":"1469_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16:177\u201389.","journal-title":"Nat Rev Endocrinol"},{"key":"1469_CR41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/cld.930","volume":"16","author":"M Eslam","year":"2020","unstructured":"Eslam M, Chen F, George J. Nafld in lean Asians. Clin Liver Dis. 2020;16:240\u20133.","journal-title":"Clin Liver Dis"},{"key":"1469_CR42","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","volume":"20","author":"I Graupera","year":"2022","unstructured":"Graupera I, Thiele M, Serra-Burriel M, Caballeria L, Roulot D, Wong GL, et al. Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population. Clin Gastroenterol Hepatol. 2022;20:2567-2576.e2566.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01469-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-025-01469-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01469-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:21:41Z","timestamp":1759407701000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-025-01469-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1469"],"URL":"https:\/\/doi.org\/10.1186\/s13578-025-01469-9","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agree to publish this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}